These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 10756552)

  • 41. The president speaks: prevention is best: lessons from protecting the ozone layer.
    Woodcock A
    Thorax; 2012 Dec; 67(12):1028-31. PubMed ID: 23019254
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Withdrawal of albuterol inhalers containing chlorofluorocarbon propellants.
    Hendeles L; Colice GL; Meyer RJ
    N Engl J Med; 2007 Mar; 356(13):1344-51. PubMed ID: 17392304
    [No Abstract]   [Full Text] [Related]  

  • 43. Review of therapeutically equivalent alternatives to short acting beta(2) adrenoceptor agonists delivered via chlorofluorocarbon-containing inhalers.
    Hughes DA; Woodcock A; Walley T
    Thorax; 1999 Dec; 54(12):1087-92. PubMed ID: 10567628
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Is inhaled beclomethasone (BDP) with a non-CFC propellant equivalent to the CFC propellant formulations?
    Chrystyn H
    Respir Med; 2000 Feb; 94(2):177-9; author reply 179-80. PubMed ID: 10714428
    [No Abstract]   [Full Text] [Related]  

  • 45. Inhaled beclomethasone (BDP) with non-CFC propellant (HFA 134a) is equivalent to BDP-CFC for the treatment of asthma (Respir Med 1999; 93: 245-251).
    Pavord ID
    Respir Med; 2000 Feb; 94(2):182-3; author reply 183. PubMed ID: 10714431
    [No Abstract]   [Full Text] [Related]  

  • 46. Medical aerosol propellant interference with infrared anaesthetic gas monitors.
    Levin PD; Levin D; Avidan A
    Br J Anaesth; 2004 Jun; 92(6):865-9. PubMed ID: 15121726
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Human safety and pharmacokinetics of the CFC alternative propellants HFC 134a (1,1,1,2-tetrafluoroethane) and HFC 227 (1,1,1,2,3,3, 3-heptafluoropropane) following whole-body exposure.
    Emmen HH; Hoogendijk EM; Klöpping-Ketelaars WA; Muijser H; Duistermaat E; Ravensberg JC; Alexander DJ; Borkhataria D; Rusch GM; Schmit B
    Regul Toxicol Pharmacol; 2000 Aug; 32(1):22-35. PubMed ID: 11029265
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Chlorofluorocarbon-free inhalers: are we ready for the change?
    Partridge MR; Woodcock AA; Sheffer AL; Wanner A; Rubinfeld A
    Eur Respir J; 1998 May; 11(5):1006-8. PubMed ID: 9648947
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The ozone layer and metered dose inhalers.
    Boulet LP
    Can Respir J; 1998; 5(3):176-9. PubMed ID: 9707462
    [TBL] [Abstract][Full Text] [Related]  

  • 50. HFA inhalers.
    Koninck JC; Magro P; Khanjari F; Lemarié E; Diot P
    Pediatr Pulmonol Suppl; 2004; 26():23-5. PubMed ID: 15029583
    [No Abstract]   [Full Text] [Related]  

  • 51. The challenge of reformulation.
    Smith IJ
    J Aerosol Med; 1995; 8 Suppl 1():S19-27. PubMed ID: 10150491
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Part III: Location of asthma inflammation and the distal airways: clinical implications.
    Kraft M
    Curr Med Res Opin; 2007 Sep; 23 Suppl 3():S21-7. PubMed ID: 17925065
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Extra-fine corticosteroid aerosols from hydrofluoroalkane-134a metered-dose inhalers: potential advantages and disadvantages.
    Tashkin DP
    Chest; 1999 Feb; 115(2):316-8. PubMed ID: 10027423
    [No Abstract]   [Full Text] [Related]  

  • 54. Continuing patient care with metered-dose inhalers.
    Woodcock A
    J Aerosol Med; 1995; 8 Suppl 2():S5-10. PubMed ID: 10155357
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The rejuvenated pressurised metered dose inhaler.
    Bell J; Newman S
    Expert Opin Drug Deliv; 2007 May; 4(3):215-34. PubMed ID: 17489650
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Chlorofluorocarbon to hydrofluoroalkane formulations: an industry perspective.
    Atkins P
    J Allergy Clin Immunol; 1999 Dec; 104(6):S268-70. PubMed ID: 10588988
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The formulation and evaluation of a CFC-free budesonide pressurised metered dose inhaler.
    Ganderton D; Lewis D; Davies R; Meakin B; Church T
    Respir Med; 2003 Nov; 97 Suppl D():S4-9. PubMed ID: 14753246
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Application of USP inlet extensions to the TSI impactor system 3306/3320 using HFA 227 based solution metered dose inhalers.
    Mogalian E; Myrdal PB
    Drug Dev Ind Pharm; 2005 Dec; 31(10):977-85. PubMed ID: 16316853
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Isothermal microcalorimetry of pressurized systems I: a rapid method to evaluate pressurized metered dose inhaler formulations.
    D'Sa DJ; Lechuga-Ballesteros D; Chan HK
    Pharm Res; 2014 Oct; 31(10):2716-23. PubMed ID: 24760449
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Transport and deposition of beclomethasone dipropionate drug aerosols with varying ethanol concentration in severe asthmatic subjects.
    Rajaraman PK; Choi J; Babiskin A; Walenga R; Lin CL
    Int J Pharm; 2023 Apr; 636():122805. PubMed ID: 36898619
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.